Dr. Ike Ahmed at the Moran Eye Institute reviews latest MIGS innovations and discusses Iantrek’s next generation micro-interventional technology for supraciliary bio-stenting. Read about the latest clinical experience with this advanced, first-in-class MIGS technology and the unique approach for hardware-free stenting of the suprachoroidal outflow pathway. Discussed are the 12 month clinical outcomes from the BJO publication.
